… Collective mean mortality and morbidity rates were 3.7% and 6.9%, respectively (95% CI
2–5.4% and 2.1–11.6%; P < 0.001 and P = 0.004). The collective mean recurrence rate was 7.6…

… Significant improvement compared to placebo was also observed at 2 g and 4 g for the
four clinical symptoms and trips to the toilet (p≤ 0.003). Oral mesalamine capsules were …

Vascular endothelial growth factor receptor 3 (Vegfr-3) is a tyrosine kinase that is expressed
on the lymphatic endothelium and that signals for the growth of the lymphatic vessels (…

Expression of angiogenic and lymphangiogenic factors by tumours may influence the route
of metastatic spread. Vascular endothelial growth factor (VEGF) is a regulator of tumour …

… The ORs for the highest tertile of calcium intake was 0.05 (95% CI, 0.01–0.41), P trend < 0.01
among those who were Bb and did not take NSAIDs, and 0.16 (95% CI, 0.02–1.36), P trend …

… (P = 0.278), +8.2 letters versus −1.9 letters at 12 months (P = 0.167), and +18.3 letters versus
−3.4 letters at 24 months (P … from 483 μm to 562 μm after failed primary surgery (P = 0.046). …

Purpose Endogenous endophthalmitis (EE) is a sight-threatening emergency and the aetiology
is often multifactorial. Delayed diagnosis may exacerbate the poor visual prognosis. We …

… Heartburn frequency (P < 0.001) and severity (P < 0.001), as well as antacid consumed
per week (P < 0.001), were reduced in both ranitidine groups in comparison with placebo. …

Lymphatic metastasis is facilitated by lymphangiogenic growth factors VEGF-C and VEGF-D
that are secreted by some primary tumors. We identified regulation of PGDH, the key …

Purpose: Intravenous drug use (IVDU) is a known risk factor for endogenous endophthalmitis.
Endogenous fungal endophthalmitis (EFE) is emerging as a common problem among this …